Efficiency and safety of the modified protocol for cardioversion of atrial fibrillation using the antiarrhythmic drug niferidil. First results of clinical use

K. M. Dzaurova,N. Y. Mironov, Y. A. Yuricheva, V. V. Vlodzyanovsky,S. F. Sokolov,S. P. Golitsyn

EUROPEAN HEART JOURNAL(2021)

引用 0|浏览1
暂无评分
关键词
antiarrhythmic drug niferidil,atrial fibrillation,cardioversion
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要